CD8A and neoplasm: For adaptive immune responses, eATP signals via P2X7R to boost the activation, proliferation, and chemotaxis of immune cells with consequent stimulation of CD8+ and CD4+ T cell mediated anti-tumor responses (74, 76, 77).